https://doi.org/
Poster
NOT PEER REVIEWED
Download
metrics
VIEWS
753
 
downloads
96
CITE
How to cite this poster:
Milling TJ, Refaai MA, Sarode R et al. Safety of a 4-factor prothrombin complex concentrate (4F-PCC) versus plasma for vitamin K antagonist reversal: an integrated analysis of phase III clinical trial data. F1000Posters 2013, 4:103 (poster)

Safety of a 4-factor prothrombin complex concentrate (4F-PCC) versus plasma for vitamin K antagonist reversal: an integrated analysis of phase III clinical trial data

Truman J Milling, Majed A Refaai, Ravindra Sarode, Antoinette Mangione1, Billie L Durn, Joshua N Goldstein
Published 20 Mar 2013
Author Affiliations
  • Metrics
  • 753 Views
  • 96 Downloads
 
Part of the collection
Browse by related subjects
Published 20 Mar 2013

Safety of a 4-factor prothrombin complex concentrate (4F-PCC) versus plasma for vitamin K antagonist reversal: an integrated analysis of phase III clinical trial data

[version 1; not peer reviewed]

Truman J Milling, Majed A Refaai, Ravindra Sarode, Antoinette Mangione1, Billie L Durn, Joshua N Goldstein
Author Affiliations
1 CSL Behring, USA
Presented at
Annual Meeting of the Society for the Advancement of Blood Management 2012
Abstract
Competing Interests

A Mangione is a paid employee of CSL Behring.

Comments
0 Comments
 
Sign In
If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.

The email address should be the one you originally registered with F1000.

Email address not valid, please try again

You registered with F1000 via Google, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Google account password, please click here.

You registered with F1000 via Facebook, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Facebook account password, please click here.

Code not correct, please try again
Email us for further assistance.
Server error, please try again.